InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Crowley Elizabeth, Vice-Présidente Senior et Responsable de la Conformité des Produits. Insider active across 1 company, notably Celldex Therapeutics, Inc.. Cumulatively, 4 disclosures have been published. History available since 1 November 2021. The latest transaction was filed on 8 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
4,000 shares@ US$9.01650.0013% mcap30.4% of flowCommon StockSEC:0001179110-21-010819:0
4,000 shares@ US$9.01650.0013% mcap60.8% of flowCommon StockSEC:0001179110-21-010819
8,555 shares@ US$2.780.0008% mcap19.6% of flowCommon StockSEC:0001179110-21-009816:0
8,555 shares@ US$2.780.0008% mcap39.2% of flowCommon StockSEC:0001179110-21-009816
4 of 4 declarations
About Crowley Elizabeth
Elizabeth Crowley serves as Senior Vice President and Chief Product Development Officer at Celldex Therapeutics, Inc. She is responsible for ensuring that the company's products meet regulatory standards. Her expertise is essential in ensuring the safety and efficacy of the products.
